JOEL GOLDBERG: Open Payments
NPI 1699714402 · UPPER CHICHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$873 in 46 payments from 14 companies in 2025. Trend: 2023 $457 · 2024 $514 · 2025 $873
Food & beverage: $873
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $193 |
| ABBVIE INC. | 10 | $161 |
| Novo Nordisk Inc | 4 | $98 |
| GlaxoSmithKline, LLC. | 4 | $94 |
| Braeburn Inc. | 5 | $80 |
| Exact Sciences Corporation | 3 | $66 |
| PFIZER INC. | 2 | $32 |
| Cipher Pharmaceuticals US LLC | 1 | $27 |
| Lilly USA, LLC | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
Products named: VRAYLAR, AIRSUPRA, TRELEGY ELLIPTA, BREZTRI, BRIXADI, Rybelsus, Cologuard Collection Kit, PREVNAR 20.
Industry payments across PA — which companies pay providers there.
